China Universal Asset Management Co., Ltd. 89bio, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in 89bio, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 24,932 shares of ETNB stock, worth $221,146. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,932
Previous 20,370
22.4%
Holding current value
$221,146
Previous $150,000
27.33%
% of portfolio
0.02%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding ETNB
# of Institutions
173Shares Held
125MCall Options Held
78.7KPut Options Held
979K-
Janus Henderson Group PLC London, X016.5MShares$146 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$126 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$90.5 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$66.3 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$62.2 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $412M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...